518 related articles for article (PubMed ID: 18951608)
1. Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment.
Muñoz I; José Gómez M; Molina-Díaz A; Huijbregts MA; Fernández-Alba AR; García-Calvo E
Chemosphere; 2008 Dec; 74(1):37-44. PubMed ID: 18951608
[TBL] [Abstract][Full Text] [Related]
2. Life Cycle Assessment of urban wastewater reuse with ozonation as tertiary treatment: a focus on toxicity-related impacts.
Muñoz I; Rodríguez A; Rosal R; Fernández-Alba AR
Sci Total Environ; 2009 Feb; 407(4):1245-56. PubMed ID: 19036408
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
4. Weighing environmental advantages and disadvantages of advanced wastewater treatment of micro-pollutants using environmental life cycle assessment.
Wenzel H; Larsen HF; Clauson-Kaas J; Høibye L; Jacobsen BN
Water Sci Technol; 2008; 57(1):27-32. PubMed ID: 18192737
[TBL] [Abstract][Full Text] [Related]
5. Net environmental benefit: introducing a new LCA approach on wastewater treatment systems.
Godin D; Bouchard C; Vanrolleghem PA
Water Sci Technol; 2012; 65(9):1624-31. PubMed ID: 22508125
[TBL] [Abstract][Full Text] [Related]
6. Environmental assessment of urban wastewater reuse: treatment alternatives and applications.
Meneses M; Pasqualino JC; Castells F
Chemosphere; 2010 Sep; 81(2):266-72. PubMed ID: 20580058
[TBL] [Abstract][Full Text] [Related]
7. Integrated environmental assessment of tertiary and residuals treatment--LCA in the wastewater industry.
Beavis P; Lundie S
Water Sci Technol; 2003; 47(7-8):109-16. PubMed ID: 12793669
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of pharmaceuticals and personal care products along the West Prong Little Pigeon River in east Tennessee, USA.
Yu CP; Chu KH
Chemosphere; 2009 Jun; 75(10):1281-6. PubMed ID: 19395062
[TBL] [Abstract][Full Text] [Related]
9. Life cycle assessment of a coupled solar photocatalytic-biological process for wastewater treatment.
Muñoz I; Peral J; Ayllón JA; Malato S; Passarinho P; Domènech X
Water Res; 2006 Nov; 40(19):3533-40. PubMed ID: 16989886
[TBL] [Abstract][Full Text] [Related]
10. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters.
Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
Water Res; 2009 Feb; 43(2):363-80. PubMed ID: 19022470
[TBL] [Abstract][Full Text] [Related]
11. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
[TBL] [Abstract][Full Text] [Related]
12. A methodology for ranking and hazard identification of xenobiotic organic compounds in urban stormwater.
Baun A; Eriksson E; Ledin A; Mikkelsen PS
Sci Total Environ; 2006 Oct; 370(1):29-38. PubMed ID: 16814849
[TBL] [Abstract][Full Text] [Related]
13. Removal efficiency of pharmaceuticals and personal care products with varying wastewater treatment processes and operating conditions - conception of a database and first results.
Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
Water Sci Technol; 2008; 57(1):49-56. PubMed ID: 18192740
[TBL] [Abstract][Full Text] [Related]
14. Analysis of 65 pharmaceuticals and personal care products in 5 wastewater treatment plants in Portugal using a simplified analytical methodology.
Salgado R; Noronha JP; Oehmen A; Carvalho G; Reis MA
Water Sci Technol; 2010; 62(12):2862-71. PubMed ID: 21123916
[TBL] [Abstract][Full Text] [Related]
15. Potential chemical and microbiological risks on human health from urban wastewater reuse in agriculture. Case study of wastewater effluents in Spain.
Muñoz I; Tomàs N; Mas J; García-Reyes JF; Molina-Díaz A; Fernández-Alba AR
J Environ Sci Health B; 2010 May; 45(4):300-9. PubMed ID: 20401781
[TBL] [Abstract][Full Text] [Related]
16. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents.
Esplugas S; Bila DM; Krause LG; Dezotti M
J Hazard Mater; 2007 Nov; 149(3):631-42. PubMed ID: 17826898
[TBL] [Abstract][Full Text] [Related]
17. Can treated municipal wastewater be reused after ozonation and nanofiltration? Results from a pilot study of pharmaceutical removal in Henriksdal WWTP, Sweden.
Flyborg L; Björlenius B; Persson KM
Water Sci Technol; 2010; 61(5):1113-20. PubMed ID: 20220232
[TBL] [Abstract][Full Text] [Related]
18. Priority screening of toxic chemicals and industry sectors in the U.S. toxics release inventory: a comparison of the life cycle impact-based and risk-based assessment tools developed by U.S. EPA.
Lim SR; Lam CW; Schoenung JM
J Environ Manage; 2011 Sep; 92(9):2235-40. PubMed ID: 21561706
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical and personal care products (PPCPs) in urban receiving waters.
Ellis JB
Environ Pollut; 2006 Nov; 144(1):184-9. PubMed ID: 16500738
[TBL] [Abstract][Full Text] [Related]
20. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater.
Escher BI; Baumgartner R; Koller M; Treyer K; Lienert J; McArdell CS
Water Res; 2011 Jan; 45(1):75-92. PubMed ID: 20828784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
